KR102165486B1 - 펩타이드 - Google Patents

펩타이드 Download PDF

Info

Publication number
KR102165486B1
KR102165486B1 KR1020157012787A KR20157012787A KR102165486B1 KR 102165486 B1 KR102165486 B1 KR 102165486B1 KR 1020157012787 A KR1020157012787 A KR 1020157012787A KR 20157012787 A KR20157012787 A KR 20157012787A KR 102165486 B1 KR102165486 B1 KR 102165486B1
Authority
KR
South Korea
Prior art keywords
glu
lys
ser
gly
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020157012787A
Other languages
English (en)
Korean (ko)
Other versions
KR20150084852A (ko
Inventor
데이비드 레이트
헤더 스트리터
Original Assignee
아피토프 인터내셔날 엔브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1220328.7A external-priority patent/GB201220328D0/en
Priority claimed from GBGB1316660.8A external-priority patent/GB201316660D0/en
Application filed by 아피토프 인터내셔날 엔브이 filed Critical 아피토프 인터내셔날 엔브이
Publication of KR20150084852A publication Critical patent/KR20150084852A/ko
Application granted granted Critical
Publication of KR102165486B1 publication Critical patent/KR102165486B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020157012787A 2012-11-12 2013-11-11 펩타이드 Expired - Fee Related KR102165486B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1220328.7 2012-11-12
GBGB1220328.7A GB201220328D0 (en) 2012-11-12 2012-11-12 Peptides
GB1316660.8 2013-09-19
GBGB1316660.8A GB201316660D0 (en) 2013-09-19 2013-09-19 Peptides
PCT/IB2013/060060 WO2014072958A1 (en) 2012-11-12 2013-11-11 Peptides

Publications (2)

Publication Number Publication Date
KR20150084852A KR20150084852A (ko) 2015-07-22
KR102165486B1 true KR102165486B1 (ko) 2020-10-15

Family

ID=49627013

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157012787A Expired - Fee Related KR102165486B1 (ko) 2012-11-12 2013-11-11 펩타이드

Country Status (28)

Country Link
US (2) US20150306192A1 (enExample)
EP (1) EP2917232B1 (enExample)
JP (1) JP6247696B2 (enExample)
KR (1) KR102165486B1 (enExample)
CN (1) CN104903347B (enExample)
AU (1) AU2013343024B2 (enExample)
BR (1) BR112015010625B1 (enExample)
CA (1) CA2890835C (enExample)
CY (1) CY1119164T1 (enExample)
DK (1) DK2917232T3 (enExample)
EA (1) EA036483B1 (enExample)
ES (1) ES2626881T3 (enExample)
HR (1) HRP20170794T1 (enExample)
HU (1) HUE033586T2 (enExample)
IL (1) IL238627B (enExample)
IN (1) IN2015DN03814A (enExample)
LT (1) LT2917232T (enExample)
MX (1) MX350777B (enExample)
MY (1) MY176708A (enExample)
NZ (1) NZ708812A (enExample)
PH (1) PH12015501033B1 (enExample)
PL (1) PL2917232T3 (enExample)
PT (1) PT2917232T (enExample)
RS (1) RS56069B1 (enExample)
SG (1) SG11201503657UA (enExample)
SI (1) SI2917232T1 (enExample)
WO (1) WO2014072958A1 (enExample)
ZA (1) ZA201503127B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018127830A1 (en) 2017-01-04 2018-07-12 Apitope International Nv S-arrestin peptides and therapeutic uses thereof
US11986536B2 (en) 2019-03-23 2024-05-21 Ablevia Biotech Gmbh Compound for the sequestration of undesirable antibodies in a patient
EP3715374A1 (en) 2019-03-23 2020-09-30 Ablevia biotech GmbH Compound for the sequestration of undesirable antibodies in a patient
GB201909774D0 (en) * 2019-07-08 2019-08-21 Apitope Tech Bristol Limited Method
WO2022063887A1 (en) 2020-09-23 2022-03-31 Ablevia Biotech Gmbh Compound for increasing the efficacy of factor viii replacement therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010133834A2 (en) * 2009-05-18 2010-11-25 Apitope Technology (Bristol) Limited Peptide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1918298T3 (da) 2000-08-21 2010-11-29 Apitope Technology Bristol Ltd Peptid
WO2002060917A2 (en) * 2000-12-01 2002-08-08 Regents Of The University Of Minnesota Method to treat hemophilia
FR2842812A1 (fr) * 2002-07-26 2004-01-30 Pf Medicament Procede de solubilisation de peptides hydrophobes et leur utilisation pour generer une reponse de type ctl antitumorale ou anti-infectueuse
JP2006188507A (ja) * 2004-12-10 2006-07-20 Tokyo Univ Of Agriculture & Technology 蛋白質の溶解度向上方法
ES2386462T3 (es) * 2005-10-28 2012-08-21 Boehringer Ingelheim International Gmbh Ensayo de la actividad NS2/3 del virus de la hepatitis C
GB0723712D0 (en) * 2007-12-04 2008-01-16 Apitope Technology Bristol Ltd Peptides
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
CA2780763A1 (en) * 2009-11-13 2011-05-19 Puget Sound Blood Center Factor viii b cell epitope variants having reduced immunogenicity
US8969524B2 (en) * 2010-10-27 2015-03-03 Baxter International Inc. FVIII peptides for immune tolerance induction and immunodiagnostics

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010133834A2 (en) * 2009-05-18 2010-11-25 Apitope Technology (Bristol) Limited Peptide

Also Published As

Publication number Publication date
BR112015010625A2 (pt) 2017-08-22
HUE033586T2 (hu) 2017-12-28
US20150306192A1 (en) 2015-10-29
PH12015501033A1 (en) 2015-07-27
AU2013343024B2 (en) 2017-06-01
SG11201503657UA (en) 2015-06-29
DK2917232T3 (en) 2017-06-12
CA2890835C (en) 2021-11-23
IN2015DN03814A (enExample) 2015-10-02
HRP20170794T1 (hr) 2017-08-11
NZ708812A (en) 2019-03-29
RS56069B1 (sr) 2017-10-31
KR20150084852A (ko) 2015-07-22
PT2917232T (pt) 2017-06-09
PL2917232T3 (pl) 2017-09-29
AU2013343024A1 (en) 2015-05-21
US20210346476A1 (en) 2021-11-11
SI2917232T1 (sl) 2017-07-31
PH12015501033B1 (en) 2015-07-27
EA201590927A1 (ru) 2015-10-30
EP2917232B1 (en) 2017-03-01
ZA201503127B (en) 2016-10-26
CA2890835A1 (en) 2014-05-15
EA036483B1 (ru) 2020-11-16
CN104903347A (zh) 2015-09-09
LT2917232T (lt) 2017-06-26
EP2917232A1 (en) 2015-09-16
WO2014072958A8 (en) 2016-10-13
MY176708A (en) 2020-08-19
ES2626881T3 (es) 2017-07-26
HK1209138A1 (en) 2016-03-24
WO2014072958A1 (en) 2014-05-15
IL238627B (en) 2018-12-31
BR112015010625B1 (pt) 2023-03-07
JP6247696B2 (ja) 2017-12-13
IL238627A0 (en) 2015-06-30
MX350777B (es) 2017-09-15
CY1119164T1 (el) 2018-02-14
CN104903347B (zh) 2020-02-21
MX2015005973A (es) 2015-09-16
JP2016501182A (ja) 2016-01-18

Similar Documents

Publication Publication Date Title
JP6063402B2 (ja) Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用
US20210346476A1 (en) Modified FVIII Apitope Peptides
KR101673889B1 (ko) Ｆⅷ-유래 펩타이드
HK1172240B (en) Fviii-derived peptides and their use in tolerising haemophiliacs
HK1172240A (en) Fviii-derived peptides and their use in tolerising haemophiliacs
HK1209138B (en) Factor viii-derived peptides for use in the treatment of haemophilia a
HK1144292B (en) Fviii peptides and their use in tolerising haemophiliacs

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

X091 Application refused [patent]
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20241008

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE

Effective date: 20241008

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20241008